Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Filings
Track record
Movers
The Lead Compound
Home
›
Targets
› BCR::ABL1
BCR::ABL1
(1 companies · 1 programs)
Companies with an active program directed at BCR::ABL1.
Enliven Therapeutics, Inc.
ELVN
relcobatinib
— Chronic Myeloid Leukemia
Phase 1